access

News

EU rules PTC’s Duchenne drug can stay on the market

Going against the advice of its own advisors, the European Commission has said that PTC Therapeutics’ Translarna therapy for Duchenne muscular dystrophy (DMD) should stay

Patients

Beyond distance and stigma: AI's potential to democratise he...

Access to healthcare and health information remains vastly unequal, fuelled by factors like wealth, geography, language, and literacy.

News

Price cut unlocks NHS use of sickle cell drug Oxbryta

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after a

News

Walmart retreats from healthcare, closing clinics across US

For the last few years, Walmart has been promising to disrupt the US healthcare sector with a national network of clinics providing low-cost care and telehealth services.

News

NICE backs AbbVie’s oral therapy for migraine prevention

AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and episodic migraine prevention to be recommended by NICE for NHS patients in England and W

News

UK survey finds deep ethnic divisions in cancer diagnosis

A UK report has found that people from minority ethnic backgrounds face an average delay of a year between first noticing symptoms and gaining a diagnosis, which is more t

EU rules PTC’s Duchenne drug can stay on the market

Beyond distance and stigma: AI's potential to democratise he...

Price cut unlocks NHS use of sickle cell drug Oxbryta

Walmart retreats from healthcare, closing clinics across US

NICE backs AbbVie’s oral therapy for migraine prevention

UK survey finds deep ethnic divisions in cancer diagnosis

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

access

Editor's Picks